文献速递消化道肿瘤与早癌肝病胰腺与胆道疾病

预测肝门部胆管癌 upfront 手术的无效性:机器学习分析模型优化治疗分配

Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation.
PubMed 文献 · Hepatology · 2023-08-03

该研究基于27个西方三级转诊中心的前瞻性数据,纳入2271例肝门部胆管癌病例,其中309例(13.6%)归为「无效组」。采用Framingham心脏研究方法学建立术前评分系统预测无效结局,识别出ASA评分≥3、诊断时胆红素≥50 mmol/L、Ca19-9≥100 U/mL、术前胆管炎、门静脉受累、肿瘤直径≥3 cm及左侧切除为独立预测因素,评分系统在验证队列中AUC为0.755。

要点

  • 2271例中309例(13.6%)为无效组,即手术获益逆转且可考虑替代治疗的高危人群。
  • 独立预测因素包括ASA≥3、胆红素≥50 mmol/L、Ca19-9≥100 U/mL、术前胆管炎、门静脉受累、肿瘤≥3 cm及左侧切除。
  • 评分系统区分低、中、高三类风险,验证队列AUC 0.755。

核心结论

  • 通过评分系统可术前准确估计严重术后并发症和早期复发风险,有助于根据术前特征确定最佳管理策略(手术与非手术治疗的选择)。

研究设计与样本

  • 研究队列包含27个西方三级转诊中心的前瞻性维护数据,人群分为开发队列和验证队列。
  • 采用Framingham心脏研究方法学开发预测「无效」结局的术前评分系统。
  • 共分析2271例病例,其中309例(13.6%)归为「无效组」。

主要发现

  • ASA评分≥3(OR 1.60;p=0.005)、诊断时胆红素≥50 mmol/L(OR 1.50;p=0.025)、Ca 19-9≥100 U/mL(OR 1.73;p=0.013)、术前胆管炎(OR 1.75;p=0.002)、门静脉受累(OR 1.61;p=0.020)、肿瘤直径≥3 cm(OR 1.76;p<0.001)及左侧切除(OR 2.00;p<0.001)被确定为无效性的独立预测因素。
  • 所开发评分系统定义了三个风险等级(低、中、高),在验证队列中测试显示良好准确性(AUC 0.755)。

关键数值与推荐

  • ASA评分≥3:OR 1.60;p=0.005。
  • 诊断时胆红素≥50 mmol/L:OR 1.50;p=0.025。
  • Ca 19-9≥100 U/mL:OR 1.73;p=0.013。
  • 术前胆管炎:OR 1.75;p=0.002。
  • 门静脉受累:OR 1.61;p=0.020。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: While resection remains the only curative option for perihilar cholangiocarcinoma, it is well known that such surgery is associated with a high risk of morbidity and mortality. Nevertheless, beyond facing life-threatening complications, patients may also develop early disease recurrence, defining a "futile" outcome in perihilar cholangiocarcinoma surgery. The aim of this study is to predict the high-risk category (futile group) where surgical benefits are reversed and alternative treatments may be considered. METHODS: The study cohort included prospectively maintained data from 27 Western tertiary referral centers: the population was divided into a development and a validation cohort. The Framingham Heart Study methodology was used to develop a preoperative scoring system predicting the "futile" outcome. RESULTS: A total of 2271 cases were analyzed: among them, 309 were classified within the "futile group" (13.6%). American Society of Anesthesiology (ASA) score ≥ 3 (OR 1.60; p = 0.005), bilirubin at diagnosis ≥50 mmol/L (OR 1.50; p = 0.025), Ca 19-9 ≥ 100 U/mL (OR 1.73; p = 0.013), preoperative cholangitis (OR 1.75; p = 0.002), portal vein involvement (OR 1.61; p = 0.020), tumor diameter ≥3 cm (OR 1.76; p < 0.001), and left-sided resection (OR 2.00; p < 0.001) were identified as independent predictors of futility. The point system developed, defined three (ie, low, intermediate, and high) risk classes, which showed good accuracy (AUC 0.755) when tested on the validation cohort. CONCLUSIONS: The possibility to accurately estimate, through a point system, the risk of severe postoperative morbidity and early recurrence, could be helpful in defining the best management strategy (surgery vs. nonsurgical treatments) according to preoperative features.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Ratti F, Marino R, Olthof PB, et al. Predicting futility of upfront surgery in perihilar cholangiocarcinoma: Machine learning analytics model to optimize treatment allocation. Hepatology. 2023. PMID: 37530544. doi:10.1097/HEP.0000000000000554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。